NR3C2 and hydrops fetalis: Baseline use of major HF medications—including β-blockers, angiotensin converting enzyme inhibitors or angiotensin II receptor blockers, mineralocorticoid receptor antagonists, antiplatelets, anticoagulants, and statins—was similar between survivors and non-survivors, with no statistically significant differences observed (all p > 0.05).